Beste apotheek van Nederland

Bolona E R, Uraga M V, Haddad R M et al. Testosterone use in
men with sexual dysfunction: a systematic review and metaanalysis
of randomized placebo-controlled trials. Mayo Clin
Proc 2007;82(1):20-28.
Boolell M, Allen M J, Ballard S A et al. Sildenafil: an orally
active type 5 cyclic GMP-specific phosphodiesterase inhibitor
for the treatment of penile erectile dysfunction. Int J Impot Res
1996;8(2):47-52.
Boshier A, Wilton L V, Shakir S A W. Evaluation of the safety
of sildenafil for male erectile dysfunction: Experience gained in
general practice use in England in 1999. BJU Int
2004;93(6):796-801.
Bouloux P. Testim 1% testosterone gel for the treatment of male
hypogonadism. [Review] [33 refs]. Clin Ther 2005;27(3):286­
298.
Boydak B, Nalbantgil S, Fici F et al. A randomised comparison
of the effects of nebivolol and atenolol with and without
chlorthalidone on the sexual function of hypertensive men.
Clinical Drug Investigation 2005;25(6):409-416.
Braatvedt G D. Outcome of managing impotence in clinical
practice. N Z Med J 1999;112(1092):272-274.
Brake M, Loertzer H, Horsch R et al. Treatment of Peyronie's
disease with local interferon-alpha 2b. BJU Int 2001;87(7):654­
657.
Bratus D, Hlebic G, Hajdinjak T. 16905960 of erectile
dysfunction. Croat Med J 2007;48(1):76-80.
Brazil M. Viagra for broken hearts?. Nat Rev Genet
2005;4(3):190
Brennemann W, Kohler W, Zierz S et al. Testicular dysfunction
in adrenomyeloneuropathy. Eur J Endocrinol 1997;137(1):34­
39.
Brennemann W, Stitz B, Van Ahlen H et al. Treatment of
idiopathic erectile dysfunction in men with the opiate antagonist
naltrexone--a double-blind study. J Androl 1993;14(6):407-410.
Briganti A, Chun F K H, Salonia A et al. A comparative review
of apomorphine formulations for erectile dysfunction:
Recommendations for use in the elderly. Drugs Aging
2006;23(4):309-319.
Briganti A, Salonia A, Gallina A et al. Drug insight: Oral
phosphodiesterase type 5 inhibitors for erectile dysfunction.
Nature Clinical Practice Urology 2005;2(5):239-247.
Briganti A, Salonia A, Zanni G et al. Erectile dysfunction and
radical prostatectomy: An update. Eau Update Series
2004;2(2):84-92.
Brindis R G, Kloner R A. Sildenafil in patients with
cardiovascular disease. [Review] [33 refs]. Am J Cardiol
2003;92(9A):26M-36M.
Brixius K, Middeke M, Lichtenthal A et al. Nitric
oxide, erectile dysfunction and beta-blocker treatment
(MR NOED study): Benefit of nebivolol versus
metoprolol in hypertensive men. Clinical &
Experimental Pharmacology & Physiology
2007;34(4):327-331.
Broderick G A, Allen G, McClure R D. Vacuum
tumescence devices: the role of papaverine in the
selection of patients. Br J Urol 1991;145(2):284-286.
Brooks D P, Giuliano F. Genitourinary diseases. Drug
Discovery Today: Therapeutic Strategies
2005;2(1):iii-iiv.
Brown J S, Wessells H, Chancellor M B et al.
Urologic complications of diabetes. Diabetes Care
2005;28(1):177-185.
Buchholz N P, Weuste R, Mattarelli G et al. Postvasectomy
erectile dysfunction. J Psychosom Res
1994;38(7):759-762.
Buddeberg C, Bucher T, Hornung R. [Erectile
dysfunction in men in their second half of life].
Urologe 2005;Ausg. A. 44(9):1045-1046, 1048-51.
Buena F, Swerdloff R S, Steiner B S et al. Sexual
function does not change when serum testosterone
levels are pharmacologically varied within the normal
male range. Fertility & Sterility 1993;59(5):1118­
1123.
Bukofzer S, Livesey N. Safety and tolerability of
apomorphine SL (Uprima). Int J Impot Res
2001;13(SUPPL. 3):S40-S44.
Burls A, Gold L, Clark W. Systematic review of
randomised controlled trials of sildenafil (Viagra) in
the treatment of male erectile dysfunction. Br J
Gen.Pract. 2001;51(473):1004-1012.
Burnett A L. Efficacy of tadalafil for the treatment of
erectile dysfunction at 24 and 36 hours after dosing: A
randomized controlled trial: Editorial comment 2.
Urology 2003;62(1):126
Burnett A L. Vasoactive pharmacotherapy to cure
erectile dysfunction: fact or fiction?. [Review] [45
refs]. Urology 2005;65(2):224-230.
Burnett A L. The impact of sildenafil on molecular
science and sexual health. Eur Urol 2004;46(1):9-14.
Burns-Cox N, Gingell C. The andropause: fact or
fiction?. [Review] [49 refs]. Postgrad Med J
1997;73(863):553-556.
Buvat J. Hyperprolactinemia and sexual function in
men: a short review. [Review] [26 refs]. Int J Impot
Res 2003;15(5):373-377.
D-128